Algunas consideraciones sobre la hepatitis G

Revista Cubana de Medicina General Integral

Volumn 15, Issue 3, 1999, Pages 328-333

  Álvarez, Vladimir Ruíz ^a   Pérez, Nora Clara Benítez ^b  

^a Hosp Univ Martires del 9 de Abril   (Cuba)

^b Filial Universitaria de Ciencias Médicas Lidia Doce Sánchez   (Cuba)

Author keywords

Hepatitis agents GB isolation purificaci n; Hepatitis, viral, human Virology

Indexed keywords

EID: 53149083422     PISSN: 08642125     EISSN: 08642125     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Boyce N. Virologists rece to develop hepatitis G assay. Labmed Int 1996;13(5):22.
2. Alter HJ. The clining and clinical implications of HGV and HGV-C and [editorial]. N Engl J Med 1996;334:(23):1536-7.
3. Miyakawa Y, Mayumi M. Hepatitis G virus- a true hepatitis virus or an accidental tourist? [editorial]. N Engl J Med 1997;336(11):795-6.
4. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desal SM, Schlauder GG, et al. Identification of two flaviviras-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92: 3401-5.
5. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, et al. Genomic organization of GBV-A and GBV-B: two new members of the Flaviviridae associated with GB-agent hepatitis. J Virol 1995;69:5621-30.
6. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Guiterrez RA, Heynen CA, et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 1995;46:81-90.
7. Masuko K, Mitsui T, Iwano K, Yanazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. J Engl J Med 1996;334(23): 1485-90.
8. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, at el. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-9.
9. Alter MJ, Gallager M, Morris TT, Moyer LA, Meeks El, Krawczynski K, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336(11):741-6.
10. Bobadilla NA, Gamba G. Biología molecular en medicina V. Reacción en cadena de la polimerasa. Rev Invest Clin 1996;48:401-6.
11. Herrera JP, Gamba G. Biología molecular en medicina VI. La PCR en la práctica clínica. Rev Invest Clin 1996;48(6):479-82.
12. Leary TP, Muehoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-7.
13. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, et al. The incidence of transfussion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336(11):747-54.
14. Carreño V. Ahora sabemos que el 25 por ciento de pacientes con hepatitis crónica puede estar co-infectado con virus G. Sistole 1996;191:36-9.
15. Lamballerie X, de., Charrel RN, Dussol B. hepatitis GB virus in patients on hemodialysis [letter]. N Engl J Med 1996;334(23):1549.
16. Wang JT, Tsai FC, Lee CZ, Chen PJ, Sheu JC, Wang TH, et al. A prospective study of transfusion-transmitted GB virus. Blood 1996;88(5):1881-6.
17. Tagariello G, Infantolino D, Biasin MR, Davoli PG, Traldi A. Hepatitis G viral RNA in Italian haemofiliacs with and without hepatitis C infection [letter]. Lancet 1996;348(9029):760-1.
18. Moaven LD, Tennakoon PS, Bowden DS, Locarnini SA. Mother-to-baby transmission of hepatitis G virus. Med J Aust 1996;165(2):84-5.
19. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
20. Kudo T, Morishima T, Tsuzuki K, Orito E, Mizokami M, Hepatitis G virus in immunosuppressed paediatric allograf recipient [letter]. Lancet 1996;348(9029):751.
21. Byrnes JJ, Banks AT, Piotack MJr, Kim JP. Hepatitis G-associated aplastic anaemia [letter]. Lancet 1996;348(9025):84-5.
22. Neilson J, Harrison P, Milligan DW, Skidmore SJ, Collingham KE. Hepatitis G virus in Long-term survivors of haematological malignancy [letter]. Lancet 1996;347(9015):1632-3.